A multicenter comparison between Child Pugh and ALBI scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Edeline, J Blanc, J Johnson, P Campillo-Gimenez, B Ross, P Ma, Y King, J Hubner, Richard A Sumpter, K Darby, S
Edeline, J
Blanc, J
Johnson, P
Campillo-Gimenez, B
Ross, P
Ma, Y
King, J
Hubner, Richard A
Sumpter, K
Darby, S
Citations
Altmetric:
Abstract
The ALBI grade was proposed as an objective means to evaluate liver function in patients with Hepatocellular Carcinoma (HCC). ALBI grade 1 vs 2 were proposed as stratification factors within the Child Pugh (CP) A class. However, the original publication did not provide comparison with the sub-classification by points (5 to 15) within the CP classification.
Affiliation
Description
Date
2016-05-23
Publisher
Collections
Keywords
Type
Article
Citation
A multicenter comparison between Child Pugh and ALBI scores in patients treated with sorafenib for Hepatocellular Carcinoma. 2016: Liver Int